Annual Cash & Cash Equivalents
$132.32 M
+$116.96 M+761.21%
December 31, 2023
Summary
- As of February 7, 2025, DNTH annual cash & cash equivalents is $132.32 million, with the most recent change of +$116.96 million (+761.21%) on December 31, 2023.
- During the last 3 years, DNTH annual cash & cash equivalents has risen by +$124.69 million (+1632.46%).
- DNTH annual cash & cash equivalents is now at all-time high.
Performance
DNTH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$33.67 M
-$280.50 M-89.28%
September 30, 2024
Summary
- As of February 7, 2025, DNTH quarterly cash and cash equivalents is $33.67 million, with the most recent change of -$280.50 million (-89.28%) on September 30, 2024.
- Over the past year, DNTH quarterly cash and cash equivalents has dropped by -$123.61 million (-78.59%).
- DNTH quarterly cash and cash equivalents is now -89.79% below its all-time high of $329.72 million, reached on March 31, 2024.
Performance
DNTH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DNTH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +761.2% | -78.6% |
| 3 y3 years | +1632.5% | -78.6% |
| 5 y5 years | +1632.5% | -78.6% |
DNTH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1632.5% | -89.8% | +119.1% |
| 5 y | 5-year | at high | +1632.5% | -89.8% | +119.1% |
| alltime | all time | at high | +1632.5% | -89.8% | +119.1% |
Dianthus Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $33.67 M(-89.3%) |
| Jun 2024 | - | $314.17 M(-4.7%) |
| Mar 2024 | - | $329.72 M(+149.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $132.32 M(+761.2%) | $132.32 M(-15.9%) |
| Sep 2023 | - | $157.28 M(+923.6%) |
| Dec 2022 | $15.37 M(+101.2%) | $15.37 M |
| Dec 2021 | $7.64 M | - |
FAQ
- What is Dianthus Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual cash & cash equivalents year-on-year change?
- What is Dianthus Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Dianthus Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of DNTH is $132.32 M
What is the all time high annual cash & cash equivalents for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual cash & cash equivalents is $132.32 M
What is Dianthus Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, DNTH annual cash & cash equivalents has changed by +$116.96 M (+761.21%)
What is Dianthus Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DNTH is $33.67 M
What is the all time high quarterly cash and cash equivalents for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly cash and cash equivalents is $329.72 M
What is Dianthus Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, DNTH quarterly cash and cash equivalents has changed by -$123.61 M (-78.59%)